Table 16: Severe Hypoglycemic Episodes in Patients Treated with TRESIBA or Insulin Glargine U-100 in DEVOTE Patient Information for Tresiba TRESIBA (treSI bah) (insulin degludec) injection, for subcutaneous use Do not share your TRESIBA FlexTouch insulin delivery device with other people, even if the needle has changed
"FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions" (Press release)
Counterfeit pills could be a bigger medical problem, since they could have different purity, chemical alteration, and increased side effects. In early February, the FDA issued a warning about the distribution and use of compounded GLP-1 medications that are not federally approved
Also, shifts in blood markers of disease dont always lead to real-world improvements that patients or families can notice, especially over only two years
Prog Neurobiol 1999, 58: 31-59